Brains In Motion

https://www.facebook.com/share/1DRkZRGCX6/?mibextid=wwXIfr

A open-label study examined transcranial photobiomodulation, a non-invasive therapy that delivers 850 nm near-infrared light to targeted brain regions, in children ages 2–7 with autism spectrum disorder. Twenty-two children completed the study and received treatment twice a week for 8 weeks, with sessions gradually increased to as long as 12 minutes. Researchers targeted areas involved in communication, social processing, and brain connectivity, including the default mode network, Broca’s area, Wernicke’s area, prefrontal cortex, and occipital lobe.

After treatment, average autism severity scores on the CARS-2 scale fell by about 7 points, with reported improvements across areas such as social interaction, communication, emotional regulation, sensory responses, body use, and adaptation to change. EEG recordings also showed lower delta activity and higher beta and gamma activity, suggesting changes in brain-wave patterns over the treatment period. No moderate or severe side effects were reported, though headaches and episodes of hyperactivity occurred in some children. Because the study was small, open-label, and had no control group, larger controlled trials are still needed to confirm the effects.

Keep praying as he has an MRI today!

That’s right our very own Jen McCabe won best dietician! We already knew that but glad you all do too! Congratulations Jen!! If the gut isn’t healthy the brain isn’t either. Let us know if you want to see the best dietician!

💛 Lights on for Autism: What the Research Says about Photobiomodulation (PMID: 36412693)

A 2022 mini-review in Neurology International (“Lights on for Autism: Exploring Photobiomodulation as an Effective Therapeutic Option”) highlights why red–near-infrared light (PBM) is drawing attention for autism. The authors summarize evidence that PBM may help address several biology-first features associated with autism, including:

Mitochondrial dysfunction & oxidative stress
Neuroinflammation / gliosis
Imbalances in functional connectivity & synaptic signaling
Alterations in the gut microbiome

Early clinical reports suggest potential improvements in social communication, motivation, and irritability—paired with a strong safety profile. The authors emphasize PBM as a non-invasive, non-pharmacologic approach that merits further investigation.

Want a deeper, practical discussion?
🎧 Watch our recent webinar with Josh Madsen, DC on Transcranial PBM for Autism, ADHD, and other Neurodevelopmental Disorders—what it is, the mechanisms, emerging evidence, and what to consider if exploring it.

💛 Webinar replay: https://documentinghope.com/webinar/transcranial-photobiomodulation-for-autism-adhd-and-other-neurodevelopmental-disorders-with-josh-madsen-dc/

Welcome Rob!!